A helping of soup makes bread

Sue Hurt has benefited from medical research and wants to give something back. Picture: Bruce Hunt www.communitypix.com.au d403815
Sue Hurt has benefited from medical research and wants to give something back. Picture: Bruce Hunt www.communitypix.com.au d403815

This is the message of Swan Valley Regional Networks co-ordinator Sue Hurt who, for the past four years, has run a weekly soup kitchen in the Swan Valley with $2 of each bowl being donated to support the Leukaemia Foundation.

Her latest fundraising efforts have resulted in a $10,000 Swan Valley Community New Investigators Grant being awarded to Sharni Wilkes, of Joondanna, to develop her own research project, a smart phone medical app called Chemo@home.

‘I have been the recipient of critical medical research as I have a rare leukaemia myself, so one of the ways I want to help is to initiate a grant for young researchers ,’ Ms Hurt said.

‘Sharni will get $10,000 to expand her research project, which is a study involving a vital sign medical app, for people having a management plan at home with chemotherapy.

‘For myself, fundraising is a way to help young people to step up with research and help them on their way.’

The grant will enable West Australian blood cancer patients to take part in Ms Wilkes’ study for the new smart phone app that will continuously monitor a patient’s vital signs.

‘This is critical in blood cancer patients receiving the highly myelosuppressive chemotherapy regimens,’ Ms Wilkes said.

‘The medical app can measure a patient’s vital signs, send the information to a smart phone or tablet through wireless technology and then notify the health-care team when parameters are exceeded.’

Leukaemia Foundation Australia chief executive Adrian Collins thanked Ms Hurt and the Swan Valley community for its fundraising efforts in helping secure the research grant for the Chemo@home project.

The Leukaemia Foundation is Australia’s peak body for blood cancer, funding research and providing free services to support people with leukaemia, lymphoma, myeloma and related blood disorders.